MMP9 and prostate cancer: CRISPR/Cas9 editing of PC-3 cells showed impaired ligand-stimulated expression of MMP9, VEGF, BMP3, PSA, RUNX2, and OCN, which are involved in prostate cancer progression [2, 20, 47, 48].